"Our age of anxiety is in great part due to the result of trying to do today's jobs with yesterday's tools."
- Marshall McLuhan

The ARIS™ Automated Retinal Imaging System is a patented, fully automated system that images the inside back surface of the eye (the fundus), that includes the retina, without requiring a highly trained specialist to operate.

ARIS™ received FDA clearance to market in November of 2002, and Commercial production and shipment began in 2004.

  Key Advantages of the ARIS™

• Automation resulting in greater precision
The ARIS™ automates essentially the entire procedure for acquiring high-quality retinal images. At the start of the imaging procedure, the operator sees an image of the patient's pupil on the monitor and, using a mouse, moves the image until it is roughly centered. From that point on, the ARIS™ illuminates, then automatically completes and maintains alignment and focus, adjusts the light exposure and acquires a pair of stereo images. Typically it requires less than 15 seconds to obtain infrared, red-free and color images…all in stereo.

• Patient Comfort
With the ARIS™, patient comfort is dramatically increased. There is no discomfort due to high intensity light flashes during imaging. The ARIS™ uses infrared illumination for the pupil focus procedure and for monochrome imaging. For color imaging, colored light is used, but at much lower intensity than in existing fundus cameras. For a large percentage of the patient population, no dilation of pupils is required for acquiring images of a single field on the retina. For multiple field imaging, most clinicians will dilate the pupils as a matter of convenience and time.

• Speed
A single color, stereo-pair imaging procedure typically takes about 15 seconds to complete. A standardized diabetic retinopathy imaging procedure…seven field, stereo images…a total of twenty-eight images…takes about 5 minutes with the ARIS™, compared with about 30 minutes for a competitive fundus camera.

• Improved Documentation and Revenue Generation For The Eye Care Professional
Many ophthalmologists and optometrists presently do not do fundus photography because existing fundus cameras are time-consuming and difficult to operate. The ARIS™ allows them to produce retinal images quickly and easily using existing office personnel, thereby adding significantly to revenue. For those eye care professionals now doing retinal photography, the ARIS™ provides a dramatic increase in patient throughput while reducing operating costs.

• FDA Approval
Visual Pathways received FDA 510 (K) clearance to market ARIS™ in November, 2002.

• Patented
U.S. patent 6,296,358 covering the ARIS™ technology was issued October 2, 2001, with additional U.S. and international patents pending.

• Minimal Training Required

• Comparison
See ARIS™ fundus images following the Compairison Chart below

ARIS™70 target fields - left eye

ARIS™110 target fields - left eye

Buried Drusen

We have surveyed vision care clinicians, fundus photographers and technicians because we wanted to hear your thoughts on the “ideal” fundus camera. You told us these things were important: Automation of target selection and image acquisition; auto-pupil alignment and tracking; auto-stereo image acquisition and registration.

We heard you clearly.

Visual Pathways, Inc. is pleased to introduce the ARIS™ (Automated Retinal Imaging System), the world’s first truly automated fundus camera. With the ARIS™ brand, we’re bringing together science and technology to bring you automated imaging procedures that both the operator and patient will appreciate.

top